Intestinal ultrasound (IUS) emerges as a game-changer in the early management of Crohn’s disease, offering a non-invasive method too predict remission. According to a recent study, IUS shows that improvements in IUS parameters within the first year correlate with enhanced patient outcomes, specifically with over a third of patients achieving remission within months. this innovative … Read more
Biomedical engineers have developed an artificial intelligence (AI)–enhanced pen for personalized handwriting analysis to aid in the early diagnosis of Parkinson’s disease (PD). In a small pilot study, the “diagnostic pen” accurately recorded handwriting signals, and neural network-assisted analysis successfully distinguished PD from non-PD handwriting with greater than 95% accuracy. “Further validation through large-scale human … Read more
In Latin America, efforts to implement preventive strategies, diagnostic tools, and personalized treatment for patients with rheumatic diseases often face significant barriers. However, there have been promising developments, many of which have been driven by the growing field of genomic medicine. One such initiative is the Ibero-American Research Consortium on the Genetics of Rheumatic Diseases … Read more
BREAKING: Melanoma Adjuvant Therapy Faces Reimbursement Concerns The lack of definitive overall survival data for adjuvant therapy in stage III melanoma is prompting worries about reimbursement and treatment… The post Melanoma Adjuvant Therapy: OS Data Gaps Explained appeared first on NewsyList. Source link
Karin de Punder, PhD, a postdoctoral researcher at the University of Innsbruck, Innsbruck, Austria, has conducted research on how chronic stress accelerates the aging of the immune system and its connection to depression. Traditionally, depression has been diagnosed on the basis of self-reported symptoms; however, reliable clinical biomarkers are lacking. de Punder and colleagues have … Read more
Karin de Punder, PhD, a postdoctoral researcher at the University of Innsbruck, Innsbruck, Austria, has conducted research on how chronic stress accelerates the aging of the immune system and its connection to depression. Traditionally, depression has been diagnosed on the basis of self-reported symptoms; however, reliable clinical biomarkers are lacking. de Punder and colleagues have … Read more
This transcript has been edited for clarity. This is Dr JoAnn Manson, professor of medicine at Harvard Medical School and Brigham and Women’s Hospital. I’d like to talk with you about a recent report in the American Journal of Clinical Nutrition that suggests vitamin D supplementation has a promising role in protecting telomeres and slowing … Read more
TOPLINE: Metabolic syndrome was associated with a 24% increased risk for young-onset dementia, defined as dementia before the age of 65 years, with stronger associations found in women vs men, younger vs older adults, and individuals with vs without depression, a new study showed. METHODOLOGY: This nationwide population-based cohort study included data from more than … Read more
For the first time, the number of Americans living with Alzheimer’s disease (AD) has surpassed 7 million, according to the Alzheimer’s Disease Facts and Figures report released this week. An estimated 7.2 million people aged 65 years or older are now living with AD, up from an estimated 6.9 million in the 2024 report. Three … Read more
A novel blood test that detects a key biomarker for Alzheimer’s disease (AD) could help physicians more accurately determine the presence and track disease progression. The test measures levels of the protein MTBR-tau243 — microtubule-binding region of tau containing the residue 243 — a biomarker of tau tangles in the brain that may be a … Read more